首页 > 市场调查报告书 > 製药

OTC 非处方药

市场调查报告书

商品编码

1561903

美国消费者健康市场

Consumer Health in the US

出版日期: 2024年09月17日 | 出版商:

Euromonitor International | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

2024年美国消费者健康市场各类别将呈现温和环境。通膨压力有所缓解，价格涨幅有所放缓，而咳嗽药、感冒药和过敏药 (CCA) 等季节性类别药品在 2022 年达到高峰后继续保持稳定。随着品牌产品成本的正常化和供应链效率的提高，自有品牌产品的价格也有所下降。

本报告检视了美国消费者健康市场并提供了市场概况，包括2019年至2023年的最新零售资料、市场机会和未来展望。

由于消费者持续受到通货膨胀、经济不确定性和价格持续上涨的影响，预计 2024 年皮肤科产品的表现将好坏参半
新的政策变化和增加的服务供应预计将影响驱虫/蝨子（头部和身体）治疗的效果
消费者安全和皮肤健康的首要任务推动皮肤科产品的创新

前景和机会

消费者对天然和非药物解决方案的兴趣可能会在预测期内减缓皮肤科药物的成长
数位参与可能是提高品牌知名度、建立社区和教育消费者的一个有前途的途径
竞争环境正在加剧，美容/个人护理和处方笺产品的压力预计将增加。

分类资料

美国的 NRT 戒烟援助

主要资料结果

2024年发展

补丁格式持续表现停滞不前
海伦的国际撤资标誌着国内局势的不确定轨迹
未来将会出现更多D2C品牌

前景和机会

尼古丁戒断药物：潜在的类别颠覆者？
ZYN 尼古丁袋的不确定监管状况可能有利于传统 NRT 解决方案
美国年轻人使用电子烟和尼古丁袋的情况增加

类别指标

分类资料

美国安眠药

主要资料结果

2024年发展

随着传统产品失去主导地位，助眠剂的价值成长持续下降
天然睡眠支持成分受益于「Sleepy Girl无酒精调饮」等数位趋势
DTC 和知名品牌正在透过推出新产品来探索睡眠补充品的创新

前景和机会

老字型大小企业如何在面临威胁的领域进行创新
零售电子商务预计将在未来的助眠剂和睡眠相关类别中继续发挥关键作用
儿科睡眠产品或因担忧而失去褪黑素定位

分类资料

美国眼部护理

主要资料结果

2024年发展

过敏季节的加剧增加了对过敏眼部护理产品的需求并刺激了创新
干眼症仍然处于眼部护理产品进步的前沿
眼药水回想凸显眼健康教育的重要性

前景和机会

气候条件恶化为眼医疗产业带来机会
永续配方是优质化的关键
化妆品定位可望实现标准眼部护理

分类资料

美国创伤护理

主要资料结果

2024年发展

成熟度持续限制创伤护理的成长
Kenview 处于创伤护理领域的前沿，提供各种高品质产品。
零售电子商务成为创伤护理的热门通路

前景和机会

儘管目前受到限制，但产品创新是价值成长的关键
危险的「永久化学物质」可能会阻碍伤口护理的成长前景
成熟度和人口下降将限制数量增长，但永续性证书将是一个关键卖点

分类资料

美国维生素

主要资料结果

2024年发展

维生素价值维持稳定成长
推动成长的独特行销策略
自有品牌受惠于价格实惠与价值

前景和机会

维生素与机能性食品和饮料的竞争正在加剧
增加针对特定健康问题的个人化方法
创新是确保有价值销售持续成长的关键

分类资料

美国食品补充剂

主要资料结果

2024年发展

膳食食品的价值正在稳步增长，富含蛋白质的营养食品也受益于健康意识的提高。
健康产业併购增加
亚马逊采用新的补充品指南

前景和机会

营养食品预计将保持稳定增长。针对特定消费群组推出
促进女性健康和内在美丽的产品不断增加
多功能性和个人化获得更多动力

分类资料

美国的体重管理与健康

主要资料结果

2024年发展

体重管理和健康的价值正在直线下降
向青少年销售减肥药和增肌补充品的法律限制
改变对减重方法的看法

前景和机会

消费者在服用 GLP-1 药物后重新进入该类别的可能性
对于对体重管理感兴趣的消费者来说，与饮食和运动相关的生活方式改变仍然是首要任务
GLP-1 支援产品可协助您管理体重并改善您的健康

分类资料

美国运动营养

主要资料结果

2024年发展

随着人们对健康和健身的关注不断增加，运动营养又迎来了强劲的一年
创新在吸引更广泛的受众方面发挥关键作用
透过零售电商和全通路策略加强运动营养渗透

前景和机会

运动营养的个人化势头强劲
健康概念变得模糊，产业之间的竞争加剧。
永续运动营养获得进一步发展动力

分类资料

美国草本/传统产品

主要资料结果

2024年发展

草本/传统产品今年将持续成长
创新是草本/传统产品持续成长的关键
适应原和蘑菇作为大脑和认知健康产品的崛起

前景和机会

草药/传统食品补充剂作为减重方法的混合效果
持续关注女性健康可能会强调月经健康支持并推广管理月经疼痛的综合解决方案
对功效和安全性的担忧可能会导致进一步的监管，表明草药/传统产品的成长可能会放缓

分类资料

美国儿科消费者健康

主要资料结果

2024年发展

儿科止痛药、咳嗽感冒药和抗过敏药的需求预计将从 2022 年的高峰继续下降
将成分创新扩展到儿科睡眠产品和褪黑激素产品之外
监测营养趋势和服用均衡补充品的重要性日益增加

前景和机会

小儿止痛公司有机会透过形式和成分创新扰乱市场
推出新产品以扩大基本客群，并专注于天然/草药趋势
儿科维生素和营养食品前景光明

分类资料

简介目录

Product Code: CHUS

In 2024, the consumer health landscape in the US is marked by a moderated environment across various categories. Inflationary pressures have eased, leading to slightly slower price increases, while seasonal categories such as cough, cold, and allergy remedies (CCAs) continue to stabilise after the peaks observed in 2022. Private label offerings have also moderated, as the cost of branded products has normalised and supply chain efficiencies improved.

Euromonitor International's Consumer Health in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Consumer Health market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market's major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.

List Of Contents And Tables

EXECUTIVE SUMMARY

Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DISCLAIMER

DEFINITIONS

SOURCES

Summary 1 Research Sources

ANALGESICS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Analgesics overall to see a softer value performance in 2024
A new class of pain relief prescription medicine could bring change to analgesics
Continued momentum in topical analgesics/anaesthetic fuelled by new product launches

PROSPECTS AND OPPORTUNITIES

Aspirin and naproxen to witness continued declines over the forecast period
Emphasis on menstrual health could lead to combination menstrual pain management products
Paediatric-oriented players could disrupt analgesics through format and ingredient formulations

CATEGORY DATA

Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Cough, cold and allergy (hay fever) remedies continues its return to normality
Private label momentum slows amidst easing price pressures
Haleon's Robitussin recalled for microbial contamination

PROSPECTS AND OPPORTUNITIES

Climate change to influence stable consumer uptake for cough, cold, and allergy remedies
FDA's phenylephrine ruling could disrupt major players in cough and cold remedies
Pharyngeal preparations to experience cannibalisation from medicated confectionery

CATEGORY DATA

Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029

DIGESTIVE REMEDIES IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Digestive remedies continues to benefit from post-pandemic health changes and wellness-oriented product developments
Digestive remedies direct-to-consumer disruptor brand Wonderbelly enters CVS
Big brands and direct-to-consumer brands compete with product launches

PROSPECTS AND OPPORTUNITIES

Laxatives well-positioned for US demographic shifts
PPIs set to see significantly reduced consumer intake over the forecast period due to side-effects and substitutes
Digestive support products positioned for women's health could witness heightened mergers and acquisitions activity

CATEGORY DATA

Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029

DERMATOLOGICALS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Mixed performance expected in dermatologicals in 2024, as consumers continue struggling with inflation, economic uncertainty, and ongoing price increases
New policy changes and rise in service-based offerings expected to impact the performance of antiparasitics/lice (head and body) treatments
Top consumer priorities of safety and skin health spur innovation in dermatologicals

PROSPECTS AND OPPORTUNITIES

Consumer interest in natural and non-medicated solutions could moderate the growth of dermatologicals over the forecast period
Digital engagement could provide a promising avenue to improve brand perception, build communities, and educate consumers
The competitive environment is set to intensify, with rising pressure expected from beauty and personal care, as well as prescription-based offerings

CATEGORY DATA

Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029

NRT SMOKING CESSATION AIDS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Patch format continues to witness a stagnant performance
Haleon's international divestments hint at uncertain trajectory for the domestic landscape
More direct-to-consumer brands on the horizon

PROSPECTS AND OPPORTUNITIES

Nicotine cessation medication: Potential category disruptor?
Uncertain regulatory landscape for ZYN nicotine pouches could benefit traditional NRT solutions
Vaping and usage of nicotine pouches increasing amongst younger generations in the US

CATEGORY INDICATORS

Table 37 Number of Smokers by Gender 2019-2024

CATEGORY DATA

Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029

SLEEP AIDS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Value growth in sleep aids continues to fall as traditional products lose their edge
Natural sleep support ingredients see benefits from digital trends, such as the "sleepy girl mocktail"
DTC and legacy brands look to innovate through sleep supplementation in new product launches

PROSPECTS AND OPPORTUNITIES

How legacy players will look to innovate in a category under threat
Retail e-commerce expected to continue to play a major role in the future of sleep aids and sleep adjacent categories
Paediatric sleep products could move away from melatonin positioning due to concerns

CATEGORY DATA

Table 44 Sales of Sleep Aids: Value 2019-2024
Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029

EYE CARE IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

The heightened allergy season is driving demand for allergy eye care products and sparking innovation
Dry eye conditions remain at the forefront of advances in eye care offerings
Recalls of eye drops highlight the significance of eye health education

PROSPECTS AND OPPORTUNITIES

Worsening climate conditions present an opportunity for eye care players
Sustainable formulations will be a crucial factor in terms of premiumisation
Beauty positioning shows promise for standard eye care

CATEGORY DATA

Table 50 Sales of Eye Care by Category: Value 2019-2024
Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029

WOUND CARE IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Maturity continues to limit growth in wound care
Kenvue remains at the forefront of wound care, offering a diverse range of high-quality products
Retail e-commerce emerges as a popular distribution channel for wound care

PROSPECTS AND OPPORTUNITIES

Product innovation, while currently constrained, will be key to drive value growth
Dangerous "forever chemicals" may hinder the growth prospects for wound care
Maturity and declining population to limit volume growth; however, sustainability credentials set to become an important selling point

CATEGORY DATA

Table 56 Sales of Wound Care by Category: Value 2019-2024
Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029

VITAMINS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Vitamins maintains a steady value growth performance
Unique marketing tactics to stimulate growth
Private label benefits from affordability and value

PROSPECTS AND OPPORTUNITIES

Vitamins set to face increasing rivalry from functional food and drinks
Rise in personalised approach to focus on targeted health concerns
Innovation is key to ensuring continuous growth in value sales

CATEGORY DATA

Table 62 Sales of Vitamins by Category: Value 2019-2024
Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029

DIETARY SUPPLEMENTS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Dietary supplements experiences steady value growth; protein-rich dietary supplements benefit from heightened health awareness
The rise of mergers and acquisitions in the wellness industry
New supplement guidelines adopted by Amazon

PROSPECTS AND OPPORTUNITIES

Dietary supplements set to maintain solid growth; launches will be targeted towards specific consumer groups
Products for women's health and beauty from within on the rise
Multifunctionality and personalisation set to gain further momentum

CATEGORY DATA

Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029

WEIGHT MANAGEMENT AND WELLBEING IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Weight management and wellbeing sees a steeper value decline
Legislative restrictions on sale of diet pills and muscle-building supplements to teens
Changing perception of methods of weight loss

PROSPECTS AND OPPORTUNITIES

Consumers' potential re-entry to the category after taking GLP-1 drugs
Lifestyle shifts in terms of diet and exercise remain top-of-mind for weight management consumers
GLP-1 support products on the rise in weight management and wellbeing

CATEGORY DATA

Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029

SPORTS NUTRITION IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Another strong year for sports nutrition, owing to an increased focus on health and fitness
Innovation plays a crucial role in reaching a broader audience
Retail e-commerce and omnichannel strategy strengthen penetration of sports nutrition

PROSPECTS AND OPPORTUNITIES

Personalisation set to gain momentum in sports nutrition
Cross-industry competition increases in response to the blurring wellness concept
Sustainable sports nutrition set to gain further momentum

CATEGORY DATA

Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029

HERBAL/TRADITIONAL PRODUCTS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Herbal/traditional products experiences another year of growth
Innovation is key to maintaining growth for herbal/traditional products
Rise of adaptogens and mushrooms as brain and cognitive health products

PROSPECTS AND OPPORTUNITIES

Mixed performance of herbal/traditional dietary supplements as a method for weight loss
Continued interest in women's health could highlight menstrual health support and drive integrated solutions for managing menstrual pain
Concerns about efficacy and safety could lead to further regulation, hinting at the potential slower growth of herbal/traditional products

CATEGORY DATA

Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029

PAEDIATRIC CONSUMER HEALTH IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Paediatric analgesics and cough, cold and allergy remedies set to continue to decline from their 2022 peak
Paediatric sleep offerings to expand ingredient innovation beyond melatonin products
Increased emphasis on monitoring nutritional trends and balanced supplement intake

PROSPECTS AND OPPORTUNITIES

Opportunities for players in paediatric analgesics to disrupt the market through format and ingredient innovation
Focus on natural/herbal trends, and new launches to widen the customer base
Positive outlook for paediatric vitamins and dietary supplements

CATEGORY DATA

Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029

02-2729-4219

+886-2-2729-4219

License/价格

美国消费者健康市场

Consumer Health in the US

目录

执行摘要

市场指标

市场资料

附录

免责声明

定义

资讯来源

美国止痛药

主要资料结果

2024年发展

前景和机会

分类资料

美国的咳嗽、感冒和过敏（花粉症）治疗

主要资料结果

2024年发展

前景和机会

分类资料

美国肠胃药

主要资料结果

2024年发展

前景和机会

分类资料

美国皮肤科

主要资料结果

2024年发展

前景和机会

分类资料

美国的 NRT 戒烟援助

主要资料结果

2024年发展

前景和机会

类别指标

分类资料

美国安眠药

主要资料结果

2024年发展

前景和机会

分类资料

美国眼部护理

主要资料结果

2024年发展

前景和机会

分类资料

美国创伤护理

主要资料结果

2024年发展

前景和机会

分类资料

美国维生素

主要资料结果

2024年发展

前景和机会

分类资料

美国食品补充剂

主要资料结果

2024年发展

前景和机会

分类资料

美国的体重管理与健康

主要资料结果

2024年发展

前景和机会

分类资料

美国运动营养

主要资料结果

2024年发展

前景和机会

分类资料

美国草本/传统产品

主要资料结果

2024年发展

前景和机会

分类资料

美国儿科消费者健康

主要资料结果

2024年发展

前景和机会